Si-Yi Chen
Affiliations: | Genetic, Molecular, and Cell Biology | University of Southern California, Los Angeles, CA, United States |
Area:
Immunology, Molecular Biology, Genetics, Cell BiologyGoogle:
"Si-Yi Chen"Children
Sign in to add traineeVijayalakshmi Nandakumar | grad student | 2013 | USC |
Hae J. Won | grad student | 2013 | USC |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Wang G, Kang X, Chen KS, et al. (2020) An engineered oncolytic virus expressing PD-L1 inhibitors activates tumor neoantigen-specific T cell responses. Nature Communications. 11: 1395 |
Chen J, Liu H, Jehng T, et al. (2019) A Novel Anti-PD-L1 Vaccine for Cancer Immunotherapy and Immunoprevention. Cancers. 11 |
Guram K, Kim SS, Wu V, et al. (2019) A Threshold Model for T-Cell Activation in the Era of Checkpoint Blockade Immunotherapy. Frontiers in Immunology. 10: 491 |
Yang YC, Wang D, Jin L, et al. (2018) Circulating tumor DNA detectable in early- and late-stage colorectal cancer patients. Bioscience Reports |
Huo Y, Li BY, Lin ZF, et al. (2018) MYSM1 Is Essential for Maintaining Hematopoietic Stem Cell (HSC) Quiescence and Survival. Medical Science Monitor : International Medical Journal of Experimental and Clinical Research. 24: 2541-2549 |
Wang D, Huang XF, Hong B, et al. (2018) Efficacy of intracellular immune checkpoint-silenced DC vaccine. Jci Insight. 3 |
Chen K, Zhang J, Guan T, et al. (2017) Comparison of plasma to tissue DNA mutations in surgical patients with non-small cell lung cancer. The Journal of Thoracic and Cardiovascular Surgery |
Guo N, Lou F, Ma Y, et al. (2016) Circulating tumor DNA detection in lung cancer patients before and after surgery. Scientific Reports. 6: 33519 |
Chen KZ, Lou F, Yang F, et al. (2016) Circulating Tumor DNA Detection in Early-Stage Non-Small Cell Lung Cancer Patients by Targeted Sequencing. Scientific Reports. 6: 31985 |
Zhang J, Feng H, Zhao J, et al. (2016) IκB Kinase ε Is an NFATc1 Kinase that Inhibits T Cell Immune Response. Cell Reports |